167 related articles for article (PubMed ID: 287665)
1. The intracranial injection of drug in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity.
Abramson HA; Gettner HH; Carone PA; Rolo A; Krinsky L
J Asthma Res; 1979 Jan; 16(2):55-61. PubMed ID: 287665
[TBL] [Abstract][Full Text] [Related]
2. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
[TBL] [Abstract][Full Text] [Related]
3. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
4. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
[TBL] [Abstract][Full Text] [Related]
5. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
[No Abstract] [Full Text] [Related]
6. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
[TBL] [Abstract][Full Text] [Related]
7. Neurotransmitter basis of the behavioral effects of hallucinogens.
Rech RH; Commissaris RL
Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
[TBL] [Abstract][Full Text] [Related]
8. The effects of hallucinogens on blind monkeys.
Siegel RK; Brewster JM; Johnson CA; Jarvik ME
Int Pharmacopsychiatry; 1976; 11(3):150-6. PubMed ID: 11193
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
Bradley PB; Briggs I
Br J Pharmacol; 1974 Mar; 50(3):345-54. PubMed ID: 4277490
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of hallucinogenic drugs on behavior of the cat.
Jacobs BL; Trulson ME; Stark AD; Christoph GR
Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
[No Abstract] [Full Text] [Related]
11. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
Schoenfeld RI
Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
[TBL] [Abstract][Full Text] [Related]
12. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
Kovacic B; Domino EF
J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
[TBL] [Abstract][Full Text] [Related]
13. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
McClue SJ; Brazell C; Stahl SM
Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
[TBL] [Abstract][Full Text] [Related]
14. 'Candyflipping': synergistic discriminative effect of LSD and MDMA.
Schechter MD
Eur J Pharmacol; 1998 Jan; 341(2-3):131-4. PubMed ID: 9543229
[TBL] [Abstract][Full Text] [Related]
15. An animal behavior model for studying the actions of LSD and related hallucinogens.
Jacobs BL; Trulson ME; Stern WC
Science; 1976 Nov; 194(4266):741-3. PubMed ID: 982043
[TBL] [Abstract][Full Text] [Related]
16. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
Smythies JR; Beaton J; Benington F; Morin RD
Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
[No Abstract] [Full Text] [Related]
17. Hallucinogen-induced rotational behavior in rats.
Fleisher LN; Glick SD
Psychopharmacology (Berl); 1979 Apr; 62(2):193-200. PubMed ID: 111284
[No Abstract] [Full Text] [Related]
18. Interactions of hallucinogens at the clinical level.
Wyatt RJ; Cannon EH; Stoff DM; Gillin JC
Ann N Y Acad Sci; 1976; 281():456-86. PubMed ID: 828469
[No Abstract] [Full Text] [Related]
19. The intracranial injection of drugs in goldfish. II. Preliminary report of behavior of serotonin as a potential hallucinogen when injected intracranially and intraabdominally.
Abramson HA; Gettner HH; Rolo A
J Asthma Res; 1980 Jul; 17(4):175-6. PubMed ID: 7263584
[TBL] [Abstract][Full Text] [Related]
20. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
